Delivery Order SPE2DB20D3111-SPE2DB25FA7TD

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LISDEXAMFETAMINE 10 MG CAPSULE 100S. The Delivery Order is valued at $3,487.05 and has a performance period through March 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,070.16, is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S. This is a firm fixed-price delivery order contract with a performance period through March 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LISDEXAMFETAMINE 60 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,198.62 and a completion date of May 13, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp also holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LISDEXAMFETAMINE 10 MG CAPSULE 100S. The contract has a ceiling value of $3,939.48 and a completion date of May 13, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,783.60, is a delivery order contract for the delivery of 4567197460 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of February 7, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,274.55, is a Firm Fixed Price Delivery Order for the supply of 4567533906 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,770.19 firm fixed-price delivery order is for the supply of 4568249118 - LISDEXAMFETAMINE 20 MG CAPSULE 100S, with a period of performance through May 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 Firm Fixed Price delivery order contract is for the supply of 4567113134 LISDEXAMFETAMINE 30 MG CAPSULE 100S, which will be delivered by January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,699.70, is for the delivery of 4566995949 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order, with a period of performance through January 22, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LISDEXAMFETAMINE 30 MG CAPSULE 100S, a medication, with a ceiling value of $4,933.06. The contract is a Delivery Order and has a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. This contract award is part of a larger...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA7TD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LISDEXAMFETAMINE 20 MG CAPSULE 100S, with a ceiling value of $1,414.30 and a completion date of May 15, 2025. The contract is a firm-fixed-price arrangement and is not set aside for any specific business type.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the company's broader work supporting military healthcare programs and supplying a wide range of pharmaceutical products and medical supplies to federal agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/17/25, 1:04 AM